CSL to Acquire Vifor Pharma, a Kidney Care Leader
A Swiss company, Vifor, prides itself on "helping patients lead better, healthier lives" and also specializes in iron deficie…
CEO Paul Perreault at the 2021 STAT Summit
Leaders in science convened to discuss the most pressing topics in biotech, medicine and policy at the 2021 STAT Summit.
CSL Launches Annual Scholarship Program
Thirty-seven students receive awards in the first year of a new program for employees and dependents.
Ready to Return to Working On-Sites
Ahead of all employees soon returning to working on-sites, CSL CEO Paul Perreault puts in time at the company’s Pennsylvania …
CSL CEO Paul Perreault on Australia
“It is personal. My headquarters are in Melbourne, I want to get back,” Perreault tells the Australian Financial Review’s BOS…
A Pathway Out of the Pandemic
CSL CEO Paul Perreault talks vaccines, business confidence and innovation at a University of Melbourne event.
Speed Meeting Global Colleagues
In a year with very little business travel, CSL employees found a way to meet across the miles.
CSL CEO Gives Keynote at Patient Event
The company has maintained its focus on patients amid the challenges of the pandemic, CSL Limited CEO Paul Perreault said.
Explainer: What Is PhRMA?
CSL CEO Paul Perreault recently joined the board of the Pharmaceutical Research and Manufacturers of America.
CSL CEO Paul Perreault on Rare Disease Day
See the video Perreault shared with employees: “Reflect on the work we do and the people who count on us to keep innovating.”